Cargando…

Impacts of the COVID‐19 pandemic on pharmaceuticals in wastewater treated for beneficial reuse: Two case studies in central Pennsylvania

During the COVID‐19 pandemic, wastewater surveillance was leveraged as a powerful tool for monitoring community‐scale health. Further, the well‐known persistence of some pharmaceuticals through wastewater treatment plants spurred concerns that increased usage of pharmaceuticals during the pandemic w...

Descripción completa

Detalles Bibliográficos
Autores principales: Hayden, Kathryn R., Jones, Matthew, Elkin, Kyle R., Shreve, Michael J., Clees, William Irvin, Clark, Shirley, Mashtare, Michael L., Veith, Tamie L., Elliott, Herschel A., Watson, John E., Silverman, Justin, Richard, Thomas L., Read, Andrew F., Preisendanz, Heather E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9538887/
https://www.ncbi.nlm.nih.gov/pubmed/35919971
http://dx.doi.org/10.1002/jeq2.20398
_version_ 1784803405536952320
author Hayden, Kathryn R.
Jones, Matthew
Elkin, Kyle R.
Shreve, Michael J.
Clees, William Irvin
Clark, Shirley
Mashtare, Michael L.
Veith, Tamie L.
Elliott, Herschel A.
Watson, John E.
Silverman, Justin
Richard, Thomas L.
Read, Andrew F.
Preisendanz, Heather E.
author_facet Hayden, Kathryn R.
Jones, Matthew
Elkin, Kyle R.
Shreve, Michael J.
Clees, William Irvin
Clark, Shirley
Mashtare, Michael L.
Veith, Tamie L.
Elliott, Herschel A.
Watson, John E.
Silverman, Justin
Richard, Thomas L.
Read, Andrew F.
Preisendanz, Heather E.
author_sort Hayden, Kathryn R.
collection PubMed
description During the COVID‐19 pandemic, wastewater surveillance was leveraged as a powerful tool for monitoring community‐scale health. Further, the well‐known persistence of some pharmaceuticals through wastewater treatment plants spurred concerns that increased usage of pharmaceuticals during the pandemic would increase the concentrations in wastewater treatment plant effluent. We collected weekly influent and effluent samples from May 2020 through May 2021 from two wastewater treatment plants in central Pennsylvania, the Penn State Water Reclamation Facility and the University Area Joint Authority, that provide effluent for beneficial reuse, including for irrigation. Samples were analyzed for severe acute respiratory syndrome coronavirus 2 (influent only), two over‐the‐counter medicines (acetaminophen and naproxen), five antibiotics (ampicillin, doxycycline, ofloxacin, sulfamethoxazole, and trimethoprim), two therapeutic agents (remdesivir and dexamethasone), and hydroxychloroquine. Although there were no correlations between pharmaceutical and virus concentration, remdesivir detection occurred when the number of hospitalized patients with COVID‐19 increased, and dexamethasone detection co‐occurred with the presence of patients with COVID‐19 on ventilators. Additionally, Penn State decision‐making regarding instruction modes explained the temporal variation of influent pharmaceutical concentrations, with detection occurring primarily when students were on campus. Risk quotients calculated for pharmaceuticals with known effective and lethal concentrations at which 50% of a population is affected for fish, daphnia, and algae were generally low in the effluent; however, some acute risks from sulfamethoxazole were high when students returned to campus. Remdesivir and dexamethasone persisted through the wastewater treatment plants, thereby introducing novel pharmaceuticals directly to soils and surface water. These results highlight connections between human health and water quality and further demonstrate the broad utility of wastewater surveillance.
format Online
Article
Text
id pubmed-9538887
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-95388872022-10-11 Impacts of the COVID‐19 pandemic on pharmaceuticals in wastewater treated for beneficial reuse: Two case studies in central Pennsylvania Hayden, Kathryn R. Jones, Matthew Elkin, Kyle R. Shreve, Michael J. Clees, William Irvin Clark, Shirley Mashtare, Michael L. Veith, Tamie L. Elliott, Herschel A. Watson, John E. Silverman, Justin Richard, Thomas L. Read, Andrew F. Preisendanz, Heather E. J Environ Qual TECHNICAL REPORTS During the COVID‐19 pandemic, wastewater surveillance was leveraged as a powerful tool for monitoring community‐scale health. Further, the well‐known persistence of some pharmaceuticals through wastewater treatment plants spurred concerns that increased usage of pharmaceuticals during the pandemic would increase the concentrations in wastewater treatment plant effluent. We collected weekly influent and effluent samples from May 2020 through May 2021 from two wastewater treatment plants in central Pennsylvania, the Penn State Water Reclamation Facility and the University Area Joint Authority, that provide effluent for beneficial reuse, including for irrigation. Samples were analyzed for severe acute respiratory syndrome coronavirus 2 (influent only), two over‐the‐counter medicines (acetaminophen and naproxen), five antibiotics (ampicillin, doxycycline, ofloxacin, sulfamethoxazole, and trimethoprim), two therapeutic agents (remdesivir and dexamethasone), and hydroxychloroquine. Although there were no correlations between pharmaceutical and virus concentration, remdesivir detection occurred when the number of hospitalized patients with COVID‐19 increased, and dexamethasone detection co‐occurred with the presence of patients with COVID‐19 on ventilators. Additionally, Penn State decision‐making regarding instruction modes explained the temporal variation of influent pharmaceutical concentrations, with detection occurring primarily when students were on campus. Risk quotients calculated for pharmaceuticals with known effective and lethal concentrations at which 50% of a population is affected for fish, daphnia, and algae were generally low in the effluent; however, some acute risks from sulfamethoxazole were high when students returned to campus. Remdesivir and dexamethasone persisted through the wastewater treatment plants, thereby introducing novel pharmaceuticals directly to soils and surface water. These results highlight connections between human health and water quality and further demonstrate the broad utility of wastewater surveillance. John Wiley and Sons Inc. 2022-09-05 2022 /pmc/articles/PMC9538887/ /pubmed/35919971 http://dx.doi.org/10.1002/jeq2.20398 Text en © 2022 The Authors. Journal of Environmental Quality published by Wiley Periodicals LLC on behalf of American Society of Agronomy, Crop Science Society of America, and Soil Science Society of America. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle TECHNICAL REPORTS
Hayden, Kathryn R.
Jones, Matthew
Elkin, Kyle R.
Shreve, Michael J.
Clees, William Irvin
Clark, Shirley
Mashtare, Michael L.
Veith, Tamie L.
Elliott, Herschel A.
Watson, John E.
Silverman, Justin
Richard, Thomas L.
Read, Andrew F.
Preisendanz, Heather E.
Impacts of the COVID‐19 pandemic on pharmaceuticals in wastewater treated for beneficial reuse: Two case studies in central Pennsylvania
title Impacts of the COVID‐19 pandemic on pharmaceuticals in wastewater treated for beneficial reuse: Two case studies in central Pennsylvania
title_full Impacts of the COVID‐19 pandemic on pharmaceuticals in wastewater treated for beneficial reuse: Two case studies in central Pennsylvania
title_fullStr Impacts of the COVID‐19 pandemic on pharmaceuticals in wastewater treated for beneficial reuse: Two case studies in central Pennsylvania
title_full_unstemmed Impacts of the COVID‐19 pandemic on pharmaceuticals in wastewater treated for beneficial reuse: Two case studies in central Pennsylvania
title_short Impacts of the COVID‐19 pandemic on pharmaceuticals in wastewater treated for beneficial reuse: Two case studies in central Pennsylvania
title_sort impacts of the covid‐19 pandemic on pharmaceuticals in wastewater treated for beneficial reuse: two case studies in central pennsylvania
topic TECHNICAL REPORTS
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9538887/
https://www.ncbi.nlm.nih.gov/pubmed/35919971
http://dx.doi.org/10.1002/jeq2.20398
work_keys_str_mv AT haydenkathrynr impactsofthecovid19pandemiconpharmaceuticalsinwastewatertreatedforbeneficialreusetwocasestudiesincentralpennsylvania
AT jonesmatthew impactsofthecovid19pandemiconpharmaceuticalsinwastewatertreatedforbeneficialreusetwocasestudiesincentralpennsylvania
AT elkinkyler impactsofthecovid19pandemiconpharmaceuticalsinwastewatertreatedforbeneficialreusetwocasestudiesincentralpennsylvania
AT shrevemichaelj impactsofthecovid19pandemiconpharmaceuticalsinwastewatertreatedforbeneficialreusetwocasestudiesincentralpennsylvania
AT cleeswilliamirvin impactsofthecovid19pandemiconpharmaceuticalsinwastewatertreatedforbeneficialreusetwocasestudiesincentralpennsylvania
AT clarkshirley impactsofthecovid19pandemiconpharmaceuticalsinwastewatertreatedforbeneficialreusetwocasestudiesincentralpennsylvania
AT mashtaremichaell impactsofthecovid19pandemiconpharmaceuticalsinwastewatertreatedforbeneficialreusetwocasestudiesincentralpennsylvania
AT veithtamiel impactsofthecovid19pandemiconpharmaceuticalsinwastewatertreatedforbeneficialreusetwocasestudiesincentralpennsylvania
AT elliottherschela impactsofthecovid19pandemiconpharmaceuticalsinwastewatertreatedforbeneficialreusetwocasestudiesincentralpennsylvania
AT watsonjohne impactsofthecovid19pandemiconpharmaceuticalsinwastewatertreatedforbeneficialreusetwocasestudiesincentralpennsylvania
AT silvermanjustin impactsofthecovid19pandemiconpharmaceuticalsinwastewatertreatedforbeneficialreusetwocasestudiesincentralpennsylvania
AT richardthomasl impactsofthecovid19pandemiconpharmaceuticalsinwastewatertreatedforbeneficialreusetwocasestudiesincentralpennsylvania
AT readandrewf impactsofthecovid19pandemiconpharmaceuticalsinwastewatertreatedforbeneficialreusetwocasestudiesincentralpennsylvania
AT preisendanzheathere impactsofthecovid19pandemiconpharmaceuticalsinwastewatertreatedforbeneficialreusetwocasestudiesincentralpennsylvania